InGeNA welcomes new associate member HTANALYSTS

HTANALYSTS is an Australian health economics and policy consultancy specialising in health technology assessment, market access, and strategic evidence generation. We partner with government, industry, and research organisations to evaluate new technologies and design pathways that improve patient access to innovation. Our expertise spans economic modelling, policy analysis, stakeholder engagement, and implementation support. With deep experience across genomics, rare diseases, and innovative funding models, HTANALYSTS provides rigorous analysis and practical solutions to inform decision-making.

To learn more or get in contact with HTANALYSTS’ team, view their website here.